Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $275,954 | 3 | 80.1% |
| Grant | $60,000 | 1 | 17.4% |
| Food and Beverage | $8,233 | 474 | 2.4% |
| Travel and Lodging | $196.00 | 1 | 0.1% |
| Gift | $78.00 | 2 | 0.0% |
| Education | $18.89 | 2 | 0.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SWAN VALLEY MEDICAL INCORPORATED | $336,150 | 9 | $0 (2024) |
| Novo Nordisk Inc | $849.29 | 69 | $0 (2023) |
| Amgen Inc. | $774.85 | 44 | $0 (2021) |
| PFIZER INC. | $729.44 | 41 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $641.50 | 46 | $0 (2020) |
| GlaxoSmithKline, LLC. | $584.17 | 27 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $525.35 | 29 | $0 (2020) |
| Lilly USA, LLC | $520.06 | 30 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $472.07 | 25 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $431.13 | 26 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60,163 | 5 | SWAN VALLEY MEDICAL INCORPORATED ($60,000) |
| 2023 | $234.20 | 5 | GlaxoSmithKline, LLC. ($125.00) |
| 2022 | $27.00 | 1 | Abbott Laboratories ($27.00) |
| 2021 | $273,274 | 7 | SWAN VALLEY MEDICAL INCORPORATED ($273,196) |
| 2020 | $1,487 | 81 | Amgen Inc. ($192.63) |
| 2019 | $2,063 | 120 | PFIZER INC. ($340.39) |
| 2018 | $5,002 | 126 | SWAN VALLEY MEDICAL INCORPORATED ($2,954) |
| 2017 | $2,229 | 142 | Boehringer Ingelheim Pharmaceuticals, Inc. ($364.77) |
All Payment Transactions
487 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | SWAN VALLEY MEDICAL INCORPORATED | — | Grant | Stock, stock option, or any other ownership interest | $60,000.00 | General |
| 02/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 01/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROSCIENCE | ||||||
| 2024 | SWAN VALLEY MEDICAL INCORPORATED | — | — | — | $0.00 | Ownership |
| 08/16/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 06/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Obesity | ||||||
| 05/18/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $76.62 | General |
| Category: rezum_URO | ||||||
| 03/31/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: Heart Failure and Hypertension | ||||||
| 2023 | SWAN VALLEY MEDICAL INCORPORATED | — | — | — | $0.00 | Ownership |
| 01/19/2022 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/19/2021 | SWAN VALLEY MEDICAL INCORPORATED | — | Travel and Lodging | Cash or cash equivalent | $196.00 | General |
| 05/17/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Bone Health | ||||||
| 04/06/2021 | SWAN VALLEY MEDICAL INCORPORATED | — | Consulting Fee | Stock, stock option, or any other ownership interest | $224,000.00 | General |
| 03/23/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Bone Health | ||||||
| 03/23/2021 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 01/05/2021 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Neurology | ||||||
| 01/01/2021 | SWAN VALLEY MEDICAL INCORPORATED | — | Consulting Fee | Stock, stock option, or any other ownership interest | $49,000.00 | General |
| 12/17/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Bone Health | ||||||
| 12/10/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Neuroscience | ||||||
| 12/10/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Cardiovascular | ||||||
| 12/07/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2020 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/30/2020 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 224 | 227 | $44,069 | $8,190 |
| 2022 | 9 | 2,430 | 3,157 | $472,226 | $123,508 |
| 2021 | 10 | 3,026 | 4,461 | $653,998 | $279,422 |
| 2020 | 37 | 5,433 | 12,616 | $630,969 | $463,938 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 70 | 73 | $12,685 | $2,573 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 69 | 69 | $14,145 | $2,464 | 17.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 46 | 46 | $13,984 | $2,260 | 16.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 18 | 18 | $2,772 | $698.53 | 25.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Facility | 2023 | 21 | 21 | $483.00 | $193.83 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 752 | 1,035 | $180,162 | $48,619 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 540 | 921 | $109,590 | $38,395 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 455 | 455 | $128,744 | $22,076 | 17.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2022 | 55 | 55 | $19,980 | $5,311 | 26.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2022 | 13 | 66 | $9,408 | $2,635 | 28.0% |
| G0444 | Annual depression screening, 15 minutes | Facility | 2022 | 247 | 247 | $5,227 | $2,358 | 45.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 328 | 338 | $12,636 | $1,981 | 15.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 27 | 27 | $4,460 | $1,649 | 37.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 13 | 13 | $2,019 | $484.27 | 24.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 874 | 1,453 | $244,104 | $116,699 | 47.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 457 | 457 | $126,132 | $62,883 | 49.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 554 | 903 | $100,638 | $49,627 | 49.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Facility | 2021 | 163 | 646 | $93,896 | $16,827 | 17.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2021 | 86 | 86 | $30,960 | $14,948 | 48.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 94 | 94 | $15,416 | $5,812 | 37.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 437 | 448 | $16,128 | $3,051 | 18.9% |
| G0444 | Annual depression screening, 15 minutes | Facility | 2021 | 279 | 279 | $5,990 | $2,712 | 45.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Facility | 2021 | 21 | 21 | $7,224 | $2,525 | 35.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 34 | $6,774 | $2,406 | 35.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 13 | 13 | $3,588 | $1,253 | 34.9% |
About Dr. Hal Brown, MD
Dr. Hal Brown, MD is a Family Medicine healthcare provider based in Vero Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902804677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hal Brown, MD has received a total of $344,480 in payments from pharmaceutical and medical device companies, with $60,163 received in 2024. These payments were reported across 487 transactions from 52 companies. The most common payment nature is "Consulting Fee" ($275,954).
As a Medicare-enrolled provider, Brown has provided services to 11,113 Medicare beneficiaries, totaling 20,461 services with total Medicare billing of $875,058. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Vero Beach, FL
- Active Since 07/07/2005
- Last Updated 06/01/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902804677
Products in Payments
- ENTRESTO (Drug) $450.12
- Ozempic (Drug) $433.65
- Vascepa (Drug) $334.55
- XARELTO (Drug) $270.10
- Aimovig (Biological) $267.99
- PNEUMOVAX 23 (Biological) $259.66
- Victoza (Drug) $255.24
- Prolia (Biological) $243.86
- JARDIANCE (Drug) $225.10
- TRULICITY (Drug) $220.21
- CHANTIX (Drug) $215.30
- INJECTAFER (Drug) $214.18
- SYMBICORT (Drug) $189.50
- JANUVIA (Drug) $187.39
- LYRICA (Drug) $179.06
- PREVNAR - 13 (Biological) $164.57
- EVENITY (Biological) $164.24
- SHINGRIX (Biological) $146.27
- STIOLTO RESPIMAT (Drug) $145.41
- BASAGLAR (Drug) $140.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Vero Beach
George Gray, Md, MD
Family Medicine — Payments: $12,876
Timothy Cocks, Md Pa, MD PA
Family Medicine — Payments: $8,721
George Gray, D.o, D.O
Family Medicine — Payments: $8,608
Randy Stigliano, Do, DO
Family Medicine — Payments: $6,854
Dr. Andre Vendryes, Md, MD
Family Medicine — Payments: $6,135
Dr. Fredrick Baker, Md, MD
Family Medicine — Payments: $6,010